1Hou J,Liu Z,Gu F.Epidemiology and prevention of hepatitisB virus infection[].Int J Med Sci.2005
2Sugauchi F,Orito E,Ichida T,et al.Hepatitis B virus ofgenotype B with or without recombination with genotype C o-ver the precore region plus the core gene[].Journal of Virology.2002
3Morozov V,Pisareva M,Groudinin M.Homologous recombi-nation between different genotypes of hepatitis B virus[].Gene.2000
4Kao JH,Chen PJ,Lai MY,et al.Hepatitis B genotypes cor-relate with clinical outcomes in patients with chronic hepatitisB[].Gastroenterology.2000
5Zeng G,Wen S,Wang Z,et al.Geographic distribution,clin-ical outcomes and virological characteristics of hepatitis B virusgenotypes in China[].Journal of Viral Hepatitis.2005
7Chien RN,Yeh CT,Tsai SL,et al.Determinant for sus-tained HBeAg response to lamivudine therapy[].Hepatology.2003
8Chu CJ,Hussain M,Lok AS.Hepatitis B virus genotype B isassociated with earlier HBeAg seroconversion compared withhepatitis B virus genotype C[].Gastroenterology.2002
9Yuen MF,Wong DK,Sablon E,et al.Hepatitis B viral geno-types B and C do not affect the antiviral response to lamivudi-ne[].Antiviral Therapy.2003
10Zollner B,Petersen J,Schroter M,et al.20-fold increase inrisk of lamivudine resistance in hepatitis B virus subtype adw[].The Lancet.2001
6Honkoop P, de Man RA. Entecavir: a potent new antiviral drug for hepatitis B [J]. Expert Opin Investig Drugs,2003, 12(4):683-688.
7Seifer M, Hamatake RK, Colonno RJ, et al. In vitro inhibition of hepadnavirus polymerases by the triphosphates of BMS-200475 and lobucavir [J]. Antimicrob Agents Chemother, 1998, 42(12):3200-3208.
8de Man RA, Wolters LM, Nevens F, et al. Safety and efficacy of oral entecavir given for 28 days in patients with chronic hepatitis B virus infection[J]. Hepatology, 2001,34(3):578-582.
9Lai CL, Rosmawati M, Lao J, et al. Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection [J]. Gastroenterology, 2002, 123(6):1831-1838.
10Strausberg RL, Feingold EA, Grouse LH, et al. Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences[J]. Proc Natl Acad Sci U S A, 2002, 99(26):16899-16903.
